Evidence map›Paper›PMID 39239158›Full record

ArticlePublic health action2024

Continuous quality improvement in a community-wide TB screening and prevention programme in Papua New Guinea.

N P Pank, A Aung, G Kama, A Murray, K L Huang, J Greig, M Bauri, G Chan, C Masah, K Kaison and 18 more

Abstract read
In one paragraph

Article in Public health action, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

N P PankBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
A AungBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
G KamaWestern Provincial Health Authority, Daru, Western Province, Papua New Guinea.
A MurrayBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
K L HuangBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
J GreigBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
M BauriWestern Provincial Health Authority, Daru, Western Province, Papua New Guinea.
G ChanBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
C MasahBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
K KaisonBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
S UmaliBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
T PeterBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
C WeraBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
C VelakiBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
M AseBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
I KrangaieBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
R ViruBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
T KurumopBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
T KeamBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
S IslamBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
W PomatPNG Institute of Medical Research, Goroka, Papua New Guinea.
A MahaNational Department of Health, Port Moresby, Papua New Guinea.
M BogaWestern Provincial Health Authority, Daru, Western Province, Papua New Guinea.
M KalPNG Institute of Medical Research, Goroka, Papua New Guinea.
N WuataiWestern Provincial Health Authority, Daru, Western Province, Papua New Guinea.
S M GrahamBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
S S MajumdarBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.
T MarukutiraBurnet Institute, Daru, Western Province, Papua New Guinea and Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

settingDaru Island in Papua New Guinea (PNG) has a high prevalence of TB and multidrug-resistant TB (MDR-TB).

objectiveTo evaluate the early implementation of a community-wide project to detect and treat TB disease and infection, outline the decision-making processes, and change the model of care.

designA continuous quality improvement (CQI) initiative used a plan-do-study-act (PDSA) framework for prospective implementation. Care cascades were analysed for case detection, treatment, and TB preventive treatment (TPT) initiation.

resultsOf 3,263 people screened for TB between June and December 2023, 13.7% (447/3,263) screened positive (CAD4TB or symptoms), 77.9% (348/447) had Xpert Ultra testing, 6.9% (24/348) were diagnosed with TB and all initiated treatment. For 5-34-year-olds without active TB (

conclusionCQI improved project implementation by increasing the detection of TB disease and infection and accelerating the pace of screening needed to achieve timely community-wide coverage.

Indexed as

communitycontinuous quality improvementPDSA frameworkTB

Identifiers

PMID39239158
PMCPMC11373741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.